# Dexamethasone Versus Dexmedetomidine

> **NCT03064633** · PHASE4 · COMPLETED · sponsor: **Fayoum University Hospital** · enrollment: 54 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** dexamethasone 8 mg
- **DRUG:** dexmedetomidine 80 µg
- **DRUG:** Bupivacaine 0.25% Injectable Solution

## Key facts

- **NCT ID:** NCT03064633
- **Lead sponsor:** Fayoum University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-08
- **Primary completion:** 2018-04-28
- **Final completion:** 2018-04-30
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03064633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03064633, "Dexamethasone Versus Dexmedetomidine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03064633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*